| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |